Specifications Composition (per vial): KPV 10 mg BPC-157 10 mg TB-500 10 mg GHK-Cu 50 mg (Total actives: 80 mg) Appearance: Lyophilized powder (hue may range blue-green due to copper complex) Purity: 99% (each component), HPLC/MS verified Manufacturing: GMP-compliant facility, USA Packaging: Sterile, research-grade vial Storage: 20 C, desiccated
Regulation of human trophoblast GLUT1 glucose transporter by insulin-like growth factor I (IGF-I)
Bone mineral density in patients with rheumatoid arthritis treated with infliximab
Functional Medicine Autoimmune Disease Treatments Treating Autoimmune Disease by Reducing Inflammation Systemic inflammation represents a central driver of autoimmune disease progression and symptom intensity
Zorov, D
Though similar studies on severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) have not yet been performed, due to existing similarities in these pathogens and the immunological response they trigger, recent studies have suggested that G6PD deficiency may potentially impact the prognosis, clinical outcomes, and severity of SARS-CoV-2 infection
